Miyako Capital
Overview
Miyako Capital is an independent, private venture capital firm that invests in ventures leveraging cutting-edge IP from Kyoto University and other academic and research institutions to develop new technologies. They aim to create the next-generation of leading industries and innovations by supporting industry-academic collaboration that will lead to the practical application of these new technologies in society. With a focus on seed and early-stage ventures, they invest at all stages across a wide range of technological domains and industrial sectors including life sciences, biotechnology, IT, electronics (including AI, IoT), agriculture, food, environment, energy, chemicals, and materials. They invest in ambitious teams from Japan that have the potential to succeed in the global market.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Juro Sciences | Sep 2025 | Series B | Lead |
| Fermelanta, Inc. | Aug 2025 | Series A | Co-investor |
| mui Lab株式会社 | Aug 2025 | Series B | Co-investor |
| AQAS Corporation | Jun 2025 | Series A | Co-investor |
| AQAS Corporation | Jun 2025 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.